Contineum Therapeutics (NASDAQ:CTNM) Lifted to “Strong-Buy” at Baird R W
Baird R W upgraded shares of Contineum Therapeutics (NASDAQ:CTNM – Free Report) to a strong-buy rating in a report issued on Tuesday morning, Zacks.com reports. A number of other research analysts have also weighed in on CTNM. Robert W. Baird assumed coverage on Contineum Therapeutics in a report on Tuesday. They issued an “outperform” rating […]
More Stories
MaidSafeCoin (MAID) Self Reported Market Cap Hits $137.64 Million
MaidSafeCoin (MAID) traded 0.1% lower against the U.S. dollar during the 24 hour period ending at 13:00 PM Eastern on...
Lazari Capital Management Inc. Buys 2,725 Shares of Verizon Communications Inc. (NYSE:VZ)
Lazari Capital Management Inc. lifted its position in Verizon Communications Inc. (NYSE:VZ – Free Report) by 4.0% during the 3rd...
McDonald’s Co. (NYSE:MCD) Shares Sold by Community Trust & Investment Co.
Community Trust & Investment Co. lessened its holdings in shares of McDonald’s Co. (NYSE:MCD – Free Report) by 1.6% during...
Netflix, Inc. (NASDAQ:NFLX) Shares Sold by Saxony Capital Management LLC
Saxony Capital Management LLC cut its holdings in Netflix, Inc. (NASDAQ:NFLX – Free Report) by 2.9% during the third quarter,...
Macroview Investment Management LLC Has $184,000 Stock Position in Vanguard Real Estate ETF (NYSEARCA:VNQ)
Macroview Investment Management LLC lowered its holdings in shares of Vanguard Real Estate ETF (NYSEARCA:VNQ – Free Report) by 16.0%...
Courier Capital LLC Decreases Holdings in iShares Floating Rate Bond ETF (BATS:FLOT)
Courier Capital LLC trimmed its holdings in shares of iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) by 1.8%...